Tigertriever 25 Revascularization Device— 510(k) K253062
Substantially EquivalentRapid Medical , Ltd.
FDA 510(k) clearance K253062 for Tigertriever 25 Revascularization Device, Substantially Equivalent on 2026-03-12. Applicant: Rapid Medical , Ltd.. Device class: 2.
Summary
Rapid Medical's Tigertriever 25 Revascularization Device is filed under NRY, thrombus retriever catheters. The record doesn't describe the device beyond its name and that code name.
Class II, 21 CFR 870.1250. The Neurology review panel handled it as a Traditional 510(k), though the record lists Cardiovascular as the classification panel.
Rapid Medical filed from Yokneam, Israel. Review took 171 calendar days (September 22, 2025 to March 12, 2026).
Clearance details
- Applicant
- Rapid Medical , Ltd.
- Product code
- Product code NRY
- Device class
- Class 2
- Regulation
- 21 CFR 870.1250
- Advisory panel
- Cardiovascular
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- Yokneam, IL
Recent devices under product code NRY
view all- K262021 — Toro 71 Aspiration Catheter; Toro Aspiration Tubing
- K263266 — Route 92 Medical Full Length 046 Reperfusion System and Aspiration Tubing Set
- K261089 — Radical 064 Reperfusion Catheter; Radical 076 Reperfusion Catheter; Radical Aspiration Tubing Kit
- K260617 — Tigertriever 13 Ultra Revascularization Device
- K262398 — CEREGLIDE 57 Intermediate Catheter; Cerenovus Aspiration Tubing set
More clearances from Rapid Medical , Ltd.
view allAdverse events under product code NRY
product code NRY- Death
- 411
- Injury
- 1,712
- Malfunction
- 1,855
- Total
- 3,978
Source: openFDA MAUDE database, through . Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →
Data sourced from openFDA. This site is unofficial and independent of the FDA.